Strides Shasun rises on receiveing USFDA tentative approval for Efavirenz Tablet

26 May 2016 Evaluate

Strides Shasun is currently trading at Rs 1058.80, up by 16.50 points or 1.58% from its previous closing of Rs 1042.30 on the BSE.

The scrip opened at Rs 1042.00 and has touched a high and low of Rs 1065.40 and Rs 1032.55 respectively. So far 21633 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1412.45 on 23-Nov-2015 and a 52 week low of Rs. 848.00 on 29-Feb-2016.

Last one week high and low of the scrip stood at Rs. 1118.35 and Rs. 999.00 respectively. The current market cap of the company is Rs. 9426.77 crore.

The promoters holding in the company stood at 31.14% while Institutions and Non-Institutions held 46.98% and 21.88% respectively.

Strides Shasun has received tentative approval from the United States Food & Drug Administration (USFDA) for Efavirenz Tablet USP, 600 mg. The final approval will be received after Patent Expiry in August 2018. Efavirenz Tablet is indicated for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infected adults and adolescents.

According to IMS data, the US market for Efavirenz 600 mg Tablet is approximately $150 million. The product will be manufactured at the company’s Oral dosage facility at Bangalore and marketed by Strides in the US market.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and and semi-solids.

Strides Pharma Scien Share Price

893.70 -6.95 (-0.77%)
19-Jan-2026 09:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1651.85
Dr. Reddys Lab 1168.75
Cipla 1384.65
Zydus Lifesciences 862.40
Lupin 2150.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×